Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-004598

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
May 9, 2016
Accepted (ET)
May 17, 2016 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3May 13, 2016X1,111,111$1.80A1,666,755IBy: Lone Star Value Investors, LP
Common StockF1,F6May 9, 2016L3$6.51A40,621IBy: Separately Managed Account
Common StockF1,F6May 13, 2016L12$6.51A40,633IBy: Separately Managed Account
Common StockF1,F6May 17, 2016L45$6.51A40,678IBy: Separately Managed Account

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (Right to Buy)F2,F3$1.80May 13, 2016X1,111,111DMay 26, 2015May 26, 2020Common Stock1,111,1111,666,666I
Warrant (Right to Buy)F7,F3$6.00May 13, 2016J1,000,000AMay 13, 2016May 12, 2021Common Stock1,000,0001,000,000I
5% Convertible Note due May 2017F3$1.80May 13, 2016J—AMay 26, 2015May 26, 2019Common Stock2,777,778—I

Explanation of responses